BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8225862)

  • 41. The prevalence of glaucoma in indigenous Australians within Central Australia: the Central Australian Ocular Health Study.
    Landers J; Henderson T; Craig J
    Br J Ophthalmol; 2012 Feb; 96(2):162-6. PubMed ID: 21515560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Relation between relative afferent pupillary defect and suprathreshold automated perimetry].
    Wilhelm H; Meilinger S; Apfelstedt E
    Klin Monbl Augenheilkd; 1997 Jun; 210(6):365-9. PubMed ID: 9333662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automated perimetry detects visual field loss before manual Goldmann perimetry.
    Katz J; Tielsch JM; Quigley HA; Sommer A
    Ophthalmology; 1995 Jan; 102(1):21-6. PubMed ID: 7831036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of false-negative responses for full threshold and SITA standard perimetry in glaucoma patients and normal observers.
    Johnson CA; Sherman K; Doyle C; Wall M
    J Glaucoma; 2014; 23(5):288-92. PubMed ID: 23632399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for glaucoma in the community by non-ophthalmologically trained staff using semi automated equipment.
    Vernon SA; Henry DJ; Cater L; Jones SJ
    Eye (Lond); 1990; 4 ( Pt 1)():89-97. PubMed ID: 2182352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Documentation of glaucomatous visual field defects in threshold and suprathreshold perimetry].
    Stark H
    Klin Monbl Augenheilkd; 1992 Mar; 200(3):187-98. PubMed ID: 1578877
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of an iPad Application to Detect Moderate and Advanced Visual Field Loss in Nepal.
    Johnson CA; Thapa S; George Kong YX; Robin AL
    Am J Ophthalmol; 2017 Oct; 182():147-154. PubMed ID: 28844641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The usefulness of frequency doubling technology perimetry in glaucoma screening in health-check program].
    Kusaba K; Kawanami M; Ban Y
    Nippon Ganka Gakkai Zasshi; 2004 Sep; 108(9):554-9. PubMed ID: 15506489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Perimetric and visumetric methods for measuring individually tolerated intraocular pressure in glaucoma].
    Vodovozov AM; Anidalova GB; Pilipjanko SK; Boriskina LN
    Klin Monbl Augenheilkd; 1982 Jun; 180(6):548-50. PubMed ID: 7132180
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey.
    Tielsch JM; Katz J; Singh K; Quigley HA; Gottsch JD; Javitt J; Sommer A
    Am J Epidemiol; 1991 Nov; 134(10):1102-10. PubMed ID: 1746520
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parallel rarebits: a novel, large-scale visual field screening method.
    Lin SR; Fijalkowski N; Lin BR; Li F; Singh K; Chang RT
    Clin Exp Optom; 2014 Nov; 97(6):528-33. PubMed ID: 25331077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Accuracy of glaucoma detection with frequency-doubling perimetry.
    Trible JR; Schultz RO; Robinson JC; Rothe TL
    Am J Ophthalmol; 2000 Jun; 129(6):740-5. PubMed ID: 10926982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design of low cost glaucoma screening.
    Niessen AG; Langerhorst CT; Geijssen HC; Greve EL
    Doc Ophthalmol; 1997; 93(4):293-315. PubMed ID: 9665288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Application of oculokinetic perimetry in examination of the eye].
    Wakakura M; Kageyama M; Hamanaka T; Shimizu K; Joshita H; Shimizu T; Baba H; Kisara M; Miyata M
    Nippon Ganka Gakkai Zasshi; 1996 Jul; 100(7):551-7. PubMed ID: 8741340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A hand-held OKP chart for the screening of glaucoma: preliminary evaluation.
    Damato BE; Chyla J; McClure E; Jay JL; Allan D
    Eye (Lond); 1990; 4 ( Pt 4)():632-7. PubMed ID: 2226995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A clinical comparison of visual field testing with a new automated perimeter, the Humphrey Field Analyzer, and the Goldmann perimeter.
    Beck RW; Bergstrom TJ; Lichter PR
    Ophthalmology; 1985 Jan; 92(1):77-82. PubMed ID: 3974997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London.
    Wormald RP; Basauri E; Wright LA; Evans JR
    Eye (Lond); 1994; 8 ( Pt 3)():315-20. PubMed ID: 7958037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glaucoma screening by optometrists: positive predictive value of visual field testing.
    Newman DK; Anwar S; Jordan K
    Eye (Lond); 1998; 12 ( Pt 6)():921-4. PubMed ID: 10325986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of a continuous probability scale to display visual field damage.
    Wall M; Johnson CA; Kardon RH; Crabb DP
    Arch Ophthalmol; 2009 Jun; 127(6):749-56. PubMed ID: 19506193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Automated suprathreshold static perimetry screening for detecting neuro-ophthalmologic disease.
    Siatkowski RM; Lam BL; Anderson DR; Feuer WJ; Halikman AM
    Ophthalmology; 1996 Jun; 103(6):907-17. PubMed ID: 8643246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.